Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by ALLERGAN

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
007953 New Drug Application Approval New combination (S) Standard review drug
012583 New Drug Application Approval New formulation (P) Priority review drug
012813 New Drug Application Approval New combination (S) Standard review drug
013935 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
016144 New Drug Application Approval New manufacturer (S) Standard review drug
016624
HMS
New Drug Application Approval New molecular entity (NME) (S) Standard review drug
016851
FML
New Drug Application Approval New formulation (S) Standard review drug
017011 New Drug Application Approval New manufacturer (S) Standard review drug
017100 New Drug Application Approval New formulation (S) Standard review drug
017760
FML
New Drug Application Approval New formulation (S) Standard review drug
018155 New Drug Application Approval New formulation (S) Standard review drug (V) Orphan drug
018239 New Drug Application Approval New formulation (P) Priority review drug
019216 New Drug Application Approval New formulation (S) Standard review drug
019219 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019404 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
019525 New Drug Application Approval New combination (S) Standard review drug
019700 New Drug Application Approval New formulation (S) Standard review drug
019814 New Drug Application Approval New formulation (S) Standard review drug
019921 New Drug Application Approval New formulation (S) Standard review drug
020428 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020490 New Drug Application Approval New formulation (S) Standard review drug
020600 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020613 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020811 New Drug Application Approval New formulation (S) Standard review drug
021009 New Drug Application Approval New formulation (P) Priority review drug
021023 New Drug Application Approval New formulation (P) Priority review drug
021184 New Drug Application Approval New formulation (S) Standard review drug
021262 New Drug Application Approval New formulation (S) Standard review drug
021275 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
021398 New Drug Application Approval New combination (S) Standard review drug
021493 New Drug Application Approval New formulation (S) Standard review drug
021528 New Drug Application Approval New formulation (S) Standard review drug
021565 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021595 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021770 New Drug Application Approval New formulation (S) Standard review drug
021794 New Drug Application Approval New formulation (S) Standard review drug
022103 New Drug Application Approval New formulation (S) Standard review drug
022134 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022184 New Drug Application Approval New manufacturer (S) Standard review drug
022220 New Drug Application Approval New formulation (S) Standard review drug
022315 New Drug Application Approval New formulation (P) Priority review drug
022369 New Drug Application Approval New indication (P) Priority review drug
022427 New Drug Application Approval New manufacturer
022548 New Drug Application Approval New manufacturer (S) Standard review drug
050081 New Drug Application Approval
050091 New Drug Application Approval
050567 New Drug Application Approval New combination (S) Standard review drug
050586 New Drug Application Approval New combination (S) Standard review drug
050612 New Drug Application Approval New formulation (S) Standard review drug
050790 New Drug Application Approval New formulation (P) Priority review drug
061187 Abbreviated New Drug Application Approval
061188 Abbreviated New Drug Application Approval
062452 Abbreviated New Drug Application Approval
080028 Abbreviated New Drug Application Approval
080248 Abbreviated New Drug Application Approval
084015 Abbreviated New Drug Application Approval
087748 Abbreviated New Drug Application Approval
103000 Biologic License Application Approval

Back to Companies who have applied for FDA Drug Approval


 

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.